Theralase granted Canadian patent for cancer vaccine technology
Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) announced it has received a Canadian patent for its cancer vaccine. The newly issued patent follows the...
Stay updated with breaking news from Arkady Mandel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) announced it has received a Canadian patent for its cancer vaccine. The newly issued patent follows the...
TORONTO, ON / ACCESSWIRE / April 5, 2024 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light and/or radiation activated Photo Dynamic Compounds ("PDCs") for the...
Dr. Michael Jewett Joins Theralase(R) to Help Complete Enrollment in ...
Theralase(R) Successfully Completes Non-GLP Toxicity Analysis for Brain ...
In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®